Lexaria Bioscience Corp.

LEXX Nasdaq SEC CIK 1348362
Follow Lexaria Bioscience Corp. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $0 −100% vs same quarter last year
Net income −$2M +47.4% vs same quarter last year
EPS, diluted −$0.08 +61.9% vs same quarter last year
Operating cash flow −$1.6M +54.4% vs same quarter last year
Revenue by quarter
$84K
$183.9K
$174K
$174K
$174K
$0
$20K
$0
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$15M−$10M−$5M$0$5MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$705.9K−$11.9M
FY24$464.3K−$5.8M
FY23$226.2K−$6.7M
FY22$255.4K−$7.3M
FY21$722.7K−$4M
FY20$384.5K−$4.1M
FY19$222.6K-
FY18$433.3K-
FY17$63.6K−$1.9M
FY16$40.7K−$1.3M
FY15$14.7K−$2M
FY14$0−$1.6M
FY13--
FY12-−$538.2K
FY11-−$552.5K
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−15000%−10000%−5000%0%5000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2599.6%−1683%−1686%
FY2499%−1239.2%−1248.2%
FY2386.1%−2888.5%−2946.4%
FY2271.9%−2591.7%−2846.3%
FY2175.7%−786.8%−557.2%
FY2056%-−1062.2%
FY1989.7%--
FY1894.2%--
FY1753.3%-−3031.9%
FY16−12%−3136.8%−3136.8%
FY15−103.3%−13489.8%−13489.8%
FY14---
FY13---
FY12---
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$10.5M
FY24−$5M
FY23−$5.9M
FY22−$4.9M
FY21-
FY20−$2.6M
FY19−$3.7M
FY18-
FY17−$1.5M
FY16−$664K
FY15−$1.5M
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Lexaria Bioscience Corp.
  • Healthcare median
−15000%−10000%−5000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearLexaria Bioscience Corp.Healthcare median
FY25−1686%−30.6%
FY24−1248.2%−47%
FY23−2946.4%−58%
FY22−2846.3%−80.4%
FY21−557.2%−71.9%
FY20−1062.2%−62.2%
FY19-−46.3%
FY18-−49.6%
FY17−3031.9%−45.9%
FY16−3136.8%−36%
FY15−13489.8%−38.4%
FY14-−35.5%
FY13-−37.1%
FY12-−29.1%
FY11-−27.9%